Milan M Hirpara,Ajay N Sharma,Natasha A Mesinkovska
Milan M Hirpara
Mina Farah,Nikkia Zarabian,Dora Kanu et al.
Mina Farah et al.
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib [0.03%]
阿布昔替尼治疗 dystrophic 型交界型大疱性表皮松解症患者有效
Fang Wang,Ranran Zhang,Ying Fang et al.
Fang Wang et al.
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and the highly selective JAK1 inhibitor abrocitinib may represent a promising therapeutic o...
INDIVIDUAL ARTICLE: Real World Use of Topical Tranexamic Acid Serum in Patients With Hyperpigmentation [0.03%]
外用氨甲环酸溶液治疗色素沉着患者的真实世界应用
Jill Waibel,Vivian Bucay,Katie Beleznay et al.
Jill Waibel et al.
Hyperpigmentation and pigmentary alterations are common dermatologic concerns that remain difficult to treat. The modernized topical tranexamic acid serum (TNXA-SHOT) is a novel, patent-pending serum that contains 5% tranexamic acid, 1% ami...
Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review [0.03%]
Janus激酶抑制剂治疗皮肤病临床试验中的种族和族裔代表性系统评价
Christine Olagun-Samuel,Maame-Afua Ansah,Purvi Shakelly et al.
Christine Olagun-Samuel et al.
Background: Janus kinase (JAK) inhibitors represent promising therapies for dermatologic conditions, including psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), systemic lupus erythematosus (SLE), and viti...
Ou Jia Emilie Wang,Barinder Beenu Bajwa,Jason K Rivers
Ou Jia Emilie Wang
Background: In pre-clinical studies, exosomes activate dermal repair mechanisms, and they may show regenerative potential for skin rejuvenation, pigmentation, scarring, hair loss, and inflammatory dermatoses. However, the...
An Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color [0.03%]
肤色皮肤炎症后色素沉着的治疗和预防方案的研究
Kayla Zafar,Margaret Kabakova,Lucie Joerg et al.
Kayla Zafar et al.
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in darker skin tones. ...
Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations [0.03%]
氢醌和新兴脱色素剂：临床指南、监管历史及全球安全性考虑
Mallory A Von Lotten,Aaliyah K Bourne,Chiemelum Amechi et al.
Mallory A Von Lotten et al.
Hydroquinone has long served as the gold standard for hyperpigmentation treatment, but safety concerns, regulatory changes, and growing interest in non-hydroquinone therapies have prompted reevaluation of its role in dermatology. This revie...
Eruptive Lentiginosis Within Resolved Psoriasis Plaques: A Case Report and Systematic Review of the Literature [0.03%]
银屑病皮损消退区出现色素沉着性丘疹的一例报告及文献复习
Andrew Kosharek,Santanna Patterson,Di Yan
Andrew Kosharek
Background: Many patients with psoriasis suffer from post-inflammatory pigmentary alteration (PIPA), which remains an unmet treatment need. Eruptive lentiginosis (EL) is a rare form of PIPA where multiple dark brown macul...
Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis [0.03%]
美国皮肤病学患者兴趣分析：一项为期20年的Google趋势和劳动力研究
Yagiz Matthew Akiska,Savanna I Vidal,Mana Nasseri et al.
Yagiz Matthew Akiska et al.
Background: Dermatologists remain unevenly distributed throughout the United States (US), leading to disparities in access to dermatologic care. Objective...